by European Public Health Alliance | May 31, 2019 | Trade for health | Latest Developments
George Thurley, Alternate public health member of the European Commission Expert Group on EU Trade Agreements On the 30th April, the European Court of Justice (ECJ) ruled that the EU’s Investment Court System (ICS), as included in the EU trade deal with Canada...
by European Public Health Alliance | May 2, 2019 | Trade for health | Latest Developments
Medicines and medical devices, antimicrobial resistance and digital health in EU-U.S. regulatory cooperation activities Following the agreement on July 2018 between European Commission President Jean-Claude Juncker and US President Donald Trump to launch a new phase...
by George Thurley | May 17, 2018 | Trade for health | Latest Developments
Brussels, 17 May 2018 The European Public Health Alliance, along with Latin American and global partners, has written today to the EU Trade Commissioner Cecilia Malmström and First Vice-President Frans Timmermans to put health ahead of the interests of the tobacco...
by European Public Health Alliance | May 17, 2018 | Trade for health | Latest Developments
To: Cecilia Malmstrom, European Commissioner for Trade Frans Timmermans First Vice-president of the European Commission, responsible for Sustainable Development and Transparency Cc: Dr. Vytenis Andriukaitis, European Commissioner for Health and Food Safety Brussels,...
by EPHA | Apr 10, 2018 | Clean Air | Latest Developments, Climate Emergency & EU Green Deal, Trade for health | Latest Developments
“There is already a very good example for a successful conflict of interest policy at the UN level. Vested interests have been blacklisted under the United Nations Framework Convention on Tobacco Control, in order to protect public health policy-making from the...
by EPHA | Mar 14, 2018 | Brexit, Trade for health | Latest Developments
Eleven organisations representing patients across the UK and Europe have today, 13 March, warned EU negotiators of the risk of drugs getting stuck at borders, regulatory systems for medicines splintering and potential breakthrough research collaborations being forced...
